Page last updated: 2024-11-04

rofecoxib and Acquired Nephrogenic Diabetes Insipidus

rofecoxib has been researched along with Acquired Nephrogenic Diabetes Insipidus in 2 studies

Research Excerpts

ExcerptRelevanceReference
"He had been diagnosed clinically with nephrogenic diabetes insipidus and treated by amiloride and hydrochlorothiazide combination without a satisfactory outcome at another center since 1 year of age."1.33Efficacy of COX-2 inhibitors in a case of congenital nephrogenic diabetes insipidus. ( Hoefsloot, L; Kasap, B; Kavukçu, S; Oğün, N; Oztürk, Y; Soylu, A; Türkmen, M, 2005)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pattaragarn, A1
Alon, US1
Soylu, A1
Kasap, B1
Oğün, N1
Oztürk, Y1
Türkmen, M1
Hoefsloot, L1
Kavukçu, S1

Other Studies

2 other studies available for rofecoxib and Acquired Nephrogenic Diabetes Insipidus

ArticleYear
Treatment of congenital nephrogenic diabetes insipidus by hydrochlorothiazide and cyclooxygenase-2 inhibitor.
    Pediatric nephrology (Berlin, Germany), 2003, Volume: 18, Issue:10

    Topics: Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diabetes Insipidus, Nephro

2003
Efficacy of COX-2 inhibitors in a case of congenital nephrogenic diabetes insipidus.
    Pediatric nephrology (Berlin, Germany), 2005, Volume: 20, Issue:12

    Topics: Amiloride; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Diabetes Insipidus, Nephrogenic; Diuretics

2005